FINDEX Inc. stock analysis
Want to see JP:3649 full AI Analyst Report?
FINDEX Inc. (3649) Stock Price & Analysis
3649 Stock Chart & Stats
- Day’s Range
- JPY 847.00 - JPY 866.00
- 52-Week Range
- JPY 717.00 - JPY 1,011.00
- Previous Close
- JPY 858.00
- Volume
- N/A
- Average Volume (3M)
- 49.24K
- Market Cap
- JPY 21.97B
- Enterprise Value
- JPY 19.10B
- Total Cash (Recent Filing)
- JPY 2.47B
- Total Debt (Recent Filing)
- JPY 0
- Price to Earnings (P/E)
- 18.7
- Beta
- 0.53
- Next Earnings
- Feb 18, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Dec 29, 2026
- Dividend Yield
- 3.12%
Bulls Say, Bears Say
Bulls Say
High And Improving Profitability
Strong profitability provides FINDEX with substantial earnings capacity relative to revenue and indicates that recent growth is translating into attractive returns. Margins have expanded materially from earlier years, supporting reinvestment, resilience, and durable operating leverage over the next several quarters.
Debt-free Balance Sheet
An essentially debt-free balance sheet limits interest burden and financial risk, giving FINDEX flexibility to fund operations and pursue growth without relying heavily on borrowing. Combined with healthy equity returns and a growing capital base, this supports stability through changing business conditions.
Strong Free Cash Flow Quality
Free cash flow closely tracking net income suggests that reported earnings are converting into usable cash rather than remaining primarily accounting profits. This supports internally funded investment, shareholder returns, and balance-sheet strength, while reinforcing the durability of the company’s profitability.
Bears Say
Uneven Revenue Growth
Although 2025 revenue growth was positive, the history of declines and near-flat performance shows that expansion has not been consistently sustained. Uneven demand can make future revenue planning less predictable and may limit the pace at which strong margins translate into durable earnings growth.
Operating Cash Flow Volatility
The year-over-year decline in operating cash flow, alongside weaker conversion in some earlier periods, indicates that cash generation is less consistent than headline profitability. Continued variability could constrain the timing of investment and shareholder distributions even while free cash flow remains broadly solid.
Slight Equity Decline
A modest decline in equity despite higher earnings warrants monitoring because it suggests that balance-sheet growth did not fully retain the year’s profit. The stated data do not identify the cause, but continued contraction could gradually reduce capital support and weaken the company’s financial cushion.
FINDEX Inc. News
3649 FAQ
What was FINDEX Inc.’s price range in the past 12 months?
What is FINDEX Inc.’s market cap?
When is FINDEX Inc.’s upcoming earnings report date?
How were FINDEX Inc.’s earnings last quarter?
Is FINDEX Inc. overvalued?
Does FINDEX Inc. pay dividends?
What is FINDEX Inc.’s EPS estimate?
How many shares outstanding does FINDEX Inc. have?
What happened to FINDEX Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of FINDEX Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
FINDEX Inc.
FINDEX Inc., a company established in Tokyo in 1985, focuses on the creation, production, and distribution of medical technology systems across Japan. Their portfolio features Claio, a comprehensive medical imaging database management system utilized by hospitals of all sizes, and C-Note, a dedicated platform for managing patient progress notes. They also offer DocuMaker, a sophisticated document and data management solution engineered with various input tools to boost efficiency, and the GAP/GAP-screener, which is an advanced gaze analyzing perimeter. Additionally, FINDEX Inc. develops mobile applications for smartphones. Their services cater to a wide range of medical clients, including hospitals, clinics, and other healthcare institutions. The organization adopted its current name, FINDEX Inc., in November 2014, having previously operated as PSC Inc.
- Sector
- General
- Industry
- Medical - Healthcare Information Services
- CEO
- Teruo Aibara
- Employees
- 325
- Website
- www.findex.co.jp
- Address
- Tokyo Sankei Bldg, Tokyo, 100-0004, JP
FINDEX Inc. (3649) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 12 | 0 | 0 |










